Skip to content

A proper sedation/analgesia to enhance safety in endoscopic submucosal dissection for early gastric cancer or superficial esophageal cancer

A proper sedation/analgesia to enhance safety in endoscopic submucosal dissection for early gastric cancer or superficial esophageal cancer - A proper anesthesia for endoscopic submucosal dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033674
Enrollment
70
Registered
2018-09-01
Start date
2018-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer/superficial esophageal cancer

Interventions

Intravenous anesthesia without intubation (during ESD procedure) Systemic anesthesia without intubation (during ESD procedure)

Sponsors

Niigata University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Early gastric cancer Absolute indication; differentiated adenocarcinoma in situ no larger than 2 cm in diameter without ulcer formation Relative indication; i) Absolute indication over 2 cm in diameter ii) Absolute indication less than 3 cm with ulcer formation iii) Absolute indication, but poorly differentiated adenocarcinoma Superficial esophageal cancer Absolute indication; squamous cell carcinoma invading no deeper than the submucosa and less than two-thirds of circumference Relative indication; i) Absolute indication extending two-thirds of circumference or more ii) squamous cell carcinoma invading down to 1000 micro meter of submucosal layer

Exclusion criteria

Exclusion criteria: No indication of general anesthesia

Design outcomes

Primary

MeasureTime frame
The procedural completeness of ESD (completion rate of ESD in block and histological margin in vertical and horizontal directions on 2 weeks after ESD)

Secondary

MeasureTime frame
The frequency and severity of complications (Bleeding, perforation, aspiration pneumonia, respiratory suppression, circular disturbance, cognitive ability, and factors affecting those complications on discharge)

Countries

Japan

Contacts

Public ContactTakeshi Suda

Institute of Community Medicine, Niigata University Medical and Dental Hospital Department of Gastroenterology and Hepatology

tspitt@med.niigata-u.ac.jp81-25-777-3200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026